Home > Adam's Blog > Aortic Stenosis > SMART Clinical Trial Reveals Medtronic Evolut TAVR Treatment Advantages for Women

SMART Clinical Trial Reveals Medtronic Evolut TAVR Treatment Advantages for Women

Written By: Adam Pick, Patient Advocate, Author & Website Founder
Published: December 1, 2024

Big News! In case you missed it, the new SMART Clinical Trial just revealed important treatment advantages for women with aortic stenosis who undergo a Medtronic Evolut TAVR.

To learn more about this landmark study, I traveled to the Women’s Heart Health Congressional Day in Washington, D.C. to interview Dr. Roxana Mehran, a principal investigator of the SMART Clinical Trial. Click here to watch my interview with Dr. Roxana Mehran about the SMART Clinical Trial, TAVR and women’s heart health.

SMART Clinical Trial - Women's Heart Health with Roxanna Mehran

Many thanks to Dr. Mehran for sharing these fascinating new insights about the SMART Clinical Trial specific to women’s hearts and TAVR.

Written by Adam Pick
- Patient & Website Founder

Written by Adam Pick - Patient & Website Founder

Adam Pick is a heart valve patient and author of The Patient's Guide To Heart Valve Surgery. In 2006, Adam founded HeartValveSurgery.com to educate and empower patients. This award-winning website has helped over 10 million people fight heart valve disease. Adam has been featured by the American Heart Association and Medical News Today.